RSHO™ Parent Advocate Penny Howard Discusses CBD Hemp Oil; How Daughter’s Living Legacy Is Furthering Science and Medical Research

Medical Marijuana, Inc. (OTC: MJNA) announced today that Penny Howard, a Dallas mom who from her own volition has become a spokesperson for the Company’s subsidiary HempMeds®, was featured on Fox News Channel’s Health Talk with Dr. Manny Alvarez, who interviewed Howard about her daughter Harper’s battle with the rare genetic condition CDKL5.

In the Aug. 4 segment, “Harper’s Legacy: Family Donates 5-Year-Old’s Brain to Science After Death From Rare Condition,” Howard tells Dr. Alvarez about how her family found out about HempMeds® Real Scientific Hemp Oil™ (RSHO™) after weeks and weeks of research online.

“It’s extremely encouraging to see a reputable health professional and journalist such as Dr. Manny Alvarez feature a story on Penny Howard,” said CEO of Medical Marijuana, Inc. Dr. Stuart Titus. “We applaud Penny’s courage to continue sharing her daughter’s story, and as we’ve seen time and again in legalization efforts across the nation, families of young children with special needs are helping drive the conversation around cannabis reform by sharing their stories.”

Sadly, Harper Howard passed away on Jan. 8, 2016, due to additional medical complications beyond CDKL5, however, Howard describes to Dr. Alvarez how her daughter’s bold spirit lives on through their decision to gift her 28-month daily cannabidiol (CBD) hemp oil brain and a massive deep tissue sample to medical research. Harper Howard’s donation is already having a profound impact on medical research for a wide range of neurological conditions under the guidance of University of California San Diego School of Medicine’s lead stem cell researcher, Dr. Alysson Muotri.

In addition, posting the progress of her daughter Harper’s journey on Hope4Haper’s Facebook blog became the catalyst for the historic decision by Brazil’s government to import Medical Marijuana, Inc.’s RSHO™ – and subsidize payments for RSHO™ under the Brazilian government’s health care system.

To see Dr. Manny Alvarez’s Fox News Channel interview with RSHO™ parent advocate Penny Howard visit’s Health section.



Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829- 0070

Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)

Investor Relations Contact:
EquiNet, LLC
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500


About HempMeds®
HempMeds® offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink: MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds® is the communication hub for the Medical Marijuana Inc. portfolio of companies.

About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.